Magnetic poly(glycidyl methacrylate) microspheres for protein capture

New Biotechnology

Volumn 31, Issue 5, 2014, Pages 482-491

  Koubková, Jana ^a   Müller, Petr ^b   Hlídková, Helena ^a   Plichta, Zdeněk ^a   Proks, Vladimír ^a   Vojtěšek, Bořivoj ^b   Horák, Daniel ^a  

^a INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

^b MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLIC MONOMERS; BIOCHEMISTRY; ETHYLENE; FUNCTIONAL GROUPS; MAGNETISM; MASS SPECTROMETRY; MICROSPHERES; POLYETHYLENE GLYCOLS; PROTEINS; ELECTROPHORESIS; IRON COMPOUNDS;

CARBODIIMIDE CHEMISTRY; GLYCIDYL METHACRYLATE; MAGNETIC MICROSPHERES; NON-SPECIFIC INTERACTIONS; NONSPECIFIC ADSORPTION; POLY(GLYCIDYL METHACRYLATE); TUMOR SUPPRESSOR PROTEINS; WESTERN-BLOT ANALYSIS;

MAGNETIC BUBBLES;

2 [(METHOXYCARBONYL)METHOXY]ETHYL METHACRYLATE; CARBOXYL GROUP; ETHYLENE GLYCOL DIMETHACRYLATE; IRON OXIDE; MACROGOL; MAGNETIC NANOPARTICLE; METHACRYLIC ACID; MICROSPHERE; POLY(GLYCIDYL METHACRYLATE)MICROSPHERE; PROTEIN P53; UNCLASSIFIED DRUG; MACROGOL DERIVATIVE; MONOCLONAL ANTIBODY; POLYGLYCIDYL METHACRYLATE; POLYMETHACRYLIC ACID DERIVATIVE; ABIRATERONE ACETATE; ACRYLIC ACID METHYL ESTER; ANTIGEN; CYANAMIDE; ETHYLENE; MONOCLONAL ANTIBODY DO1; POLY(GLYCIDYL METHACRYLATE); POLYMER; PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CELL LYSATE; CONTROLLED STUDY; HYDROPHILICITY; IMMUNOPRECIPITATION; MAGNETIC FIELD; MAGNETIC SEPARATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN IMMOBILIZATION; PROTEIN POLYMERIZATION; PROTEIN PROCESSING; SCANNING ELECTRON MICROSCOPY; SWELLING; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; ANIMAL; CHEMISTRY; ISOLATION AND PURIFICATION; TUMOR CELL LINE; ADSORPTION; ANIMAL CELL; FLOW CYTOMETRY; IMMUNOCHEMISTRY; MAGNETISM; MASS SPECTROMETRY; POLYMERIZATION; PROTEIN ANALYSIS; PROTEIN ISOLATION;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CELL LINE, TUMOR; MICE; MICROSPHERES; POLYETHYLENE GLYCOLS; POLYMETHACRYLIC ACIDS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84904862478     PISSN: 18716784     EISSN: 18764347     Source Type: Journal    
DOI: 10.1016/j.nbt.2014.06.004     Document Type: Article

References (59)

1. Elaissari A. Colloidal biomolecules, biomaterials, and biomedical applications 2003, 1-26. Marcel Dekker, New York.
2. Partington K.M., Jenkinson E.J., Anderson G. A novel method of cell separation based on dual parameter immunomagnetic cell selection. J Immunol Methods 1999, 223:195-205.
3. Karumanchi R.S.M.S., Doddamane S.N., Sampangi C., Todd P.W. Field-assisted extraction of cells, particles and macromolecules. Trends Biotechnol 2002, 20:72-78.
4. Šafařík I., Šafaříková M. Magnetic techniques for the isolation and purification of proteins and peptides. BioMagn Res Technol 2004, 2:7.
5. Rittich B., Španová A., Šálek P., Němcová P., Trachtová Š., Horák D. Separation of PCR-ready DNA from dairy products using magnetic hydrophilic microspheres and poly(ethylene glycol)-NaCl water solutions. J Magn Magn Mater 2009, 321:1667-1670.
6. Rittich B., Španová A., Horák D. Functionalised magnetic microspheres with hydrophilic properties for molecular diagnostic applications. Food Res Int 2009, 42:493-498.
7. Šustrová B., Novotná L., Kučerová Z., Tichá M. Immobilization of α-chymotrypsin to magnetic particles and their use for proteolytic cleavage of porcine pepsin A. J Mol Catal B Enzym 2009, 60:22-28.
8. Horák D., Svobodová Z., Autebert J., Coudert B., Plichta Z., Královec K., et al. Albumin-coated monodisperse magnetic poly(glycidyl methacrylate) microspheres with immobilized antibodies: application to the capture of epithelial cancer cells. J Biomed Mater Res Part A 2013, 101:23-32.
9. Přikryl P., Lenfeld J., Horák D., Tichá M., Kučerová Z. Magnetic bead cellulose as a suitable support for immobilization of α-chymotrypsin. Appl Biochem Biotechnol 2012, 168:295-305.
10. Joshi P., Schilke K.F., Fry A., McGuire J., Bird K. Synthesis and evaluation of heparin immobilized side-on to polystyrene microspheres coated with end-group activated polyethylene oxide. Int J Biol Macromol 2010, 47:98-103.
11. Aggarwal P., Hall J.B., McLeland C.B., Dobrovolskaia M.A., McNeil S.E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 2009, 61:428-437.
12. Šálek P., Horák D., Bláha M. PEG-modified magnetic hypercrosslinked poly(styrene-co-divinylbenzene) microspheres to minimize sorption of serum proteins. React Funct Polym 2013, 73:1122-1129.
13. Zhang R., Li Q., Li J., Zhou W., Ye P., Gao Y., et al. Covalently coating dextran on macroporous polyglycidyl methacrylate microsphere enabled rapid protein chromatographic separation. Mater Sci Eng C 2012, 32:2628-2633.
14. Kawaguchi S., Higo Y. Effects of microwave irradiation on nonspecific protein binding in the solid phase coated with bovine serum albumin. Polym J 2005, 37:109-117.
15. Lewis A.L. Phosphorylcholine-based polymers and their use in the prevention of biofouling. Colloids Surf B Biointerfaces 2000, 18:261-275.
16. Jiang S., Cao Z. Ultralow-fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications. Adv Mater 2010, 22:920-932.
17. Xu F.J., Neoh K.G., Kang E.T. Bioactive surfaces and biomaterials via atom transfer radical polymerization. Prog Polym Sci 2009, 34:719-761.
18. Horák D., Babič M., Macková H., Beneš M.J. Preparation and properties of magnetic nano- and microsized particles for biological and environmental separations. J Sep Sci 2007, 30:1751-1772.
19. 3 nanoparticles. Eur Polym J 2009, 45:1009-1016.
20. Pollert E., Knížek K., Maryško M., Závěta K., Lančok A., Boháček J., et al. Magnetic poly(glycidyl methacrylate) microspheres containing maghemite prepared by emulsion polymeriazation. J Magn Magn Mater 2006, 306:241-247.
21. Dou J., Zhang Q., Ma M., Gu J. Fast fabrication of epoxy-functionalized magnetic polymer core-shell microspheres using glydidyl methacrylate as monomer via photo-initiated miniemulsion polymerization. J Magn Magn Mater 2012, 324:3078-3082.
22. Horák D. Uniform polymer beads of micron size. Acta Polym 1996, 47:20-28.
23. Xiao L.H., Wang T., Zhano T.Y., Zheng X., Sun L.Y., Li P., et al. Fabrication of magnetic-antimicrobial-fluorescent multifunctional hybrid microspheres and their properties. Int J Mol Sci 2013, 14:7391-7404.
24. Thomson B., Rudin A., Lajoie G. Dispersion copolymerization of styrene and divinylbenzene. II. Effect of crosslinker on particle morphology. J Appl Polym Sci 1996, 59:2009-2028.
25. Ugelstad J, Ellingsen T, Berge A, Helgée B. Magnetic polymer particles and process for the preparation thereof. PCT Patent, WO 83/03920; 1983.
26. http://www.lifetechnologies.com/.
27. Kingshott P., Thissen H., Griesser H.J. Effects of cloud-point grafting, chain length, and density of PEG layers on competitive adsorption of ocular proteins. Biomaterials 2002, 23:2043-2056.
28. Kingshott P., McArthur S., Thissen H., Castner D.G., Griesser H.J. Ultrasensitive probing of the protein resistance of PEG surfaces by secondary ion mass spectrometry. Biomaterials 2002, 23:4775-4785.
29. Unsworth L.D., Sheardown H., Brash J.L. Protein-resistant poly(ethylene oxide)-grafted surfaces: chain density-dependent multiple mechanisms of action. Langmuir 2008, 24:1924-1929.
30. Lowe S.W., Ruley H.E., Jacks T., Housman D.E. P53-dependent apoptosis modulates the cytotoxicity of anti-cancer agents. Cell 1993, 74:957-967.
31. Brown J.M., Wouters B.G. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res 1999, 59:1391-1399.
32. Morris S.M. A role for p53 in the frequency and mechanism of mutation. Mutat Res Rev Mutat Res 2002, 511:45-62.
33. Kucera E., Speiser P., Gnant M., Szabo L., Samonigg H., Hausmaninger H., et al. Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients. Eur J Cancer 1999, 35:398-405.
34. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. P53 mutations in human cancers. Science 1991, 5:49-53.
35. Collot-Teixeira S., Bass J., Denis F., Ranger-Rogez S. Human tumor suppressor p53 and DNA viruses. Rev Med Virol 2004, 14:301-319.
36. Wade M., Li Y.C., Wahl G.M. MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat Rev Cancer 2013, 13:83-96.
37. Knappskog S., Lønning P.E. P53 and its molecular basis to chemoresistance in breast cancer. Expert Opin Ther Targets 2012, 16(Suppl. 1):S23-S30.
38. Vagunda V., Šmardová J., Vagundová M., Jandáková E., Žaloudík J., Koukalová H. Correlations of breast carcinoma biomarkers and p53 tested by FASAY and immunohistochemistry. Pathol Res Pract 2003, 199:795-801.
39. Schwandner O., Schiedeck T.H.K., Bruch H.P., Duchrow M., Windhoevel U., Broll R. P53 and Bcl-2 as significant predictors of recurrence and survival in rectal cancer. Eur J Cancer 2000, 36:348-356.
40. Milner J.O. Different forms of p53 detected by monoclonal antibodies in non-dividing and dividing lymphocytes. Nature 1984, 310:143-145.
41. Kubinová Š., Horák D., Syková E. Cholesterol-modified superporous poly(2-hydroxyethyl methacrylate) scaffolds for tissue engineering. Biomaterials 2009, 30:4601-4609.
42. Overberger C.G., O'Shaughnessy T., Shalit H. The preparation of some aliphatic azo nitriles and their decomposition in solution. J Am Chem Soc 1949, 71:2661-2666.
43. Meng F., Engbers G.H.M., Gessner A., Müller R.H., Feijen J. PEGylated polystyrene particles as a model system for artificial cells. J Biomed Mater Res Part A 2004, 70:97-106.
44. Meng F., Engbers G.H.M., Feijen J. Polyethylene glycol-grafted polystyrene particles. J Biomed Mater Res Part A 2004, 70:49-58.
45. Hlídková H., Horák D., Proks V., Kučerová Z., Pekárek M., Kučka J. PEG-modified macroporous poly(glycidyl methacrylate) and poly(2-hydroxyethyl methacrylate) microspheres to reduce nonspecific protein adsorption. Macromol Biosci 2013, 13:503-511.
46. Kelly RJ. Keratin derivatives and methods of making the same. US Patent, 2009/0111750 A1; 2009.
47. Yiu H.H.P. Engineering the multifunctional surface on magnetic nanoparticles for targeted biomedical applications. Nanomedicine 2011, 6:1429-1446.
48. Schnölzer M., Alewood P., Jones A., Alewood D., Kent S.B.H. In situ neutralization in Boc-chemistry solid phase peptide synthesis. Int J Pept Res Ther 2007, 13:31-44.
49. Hrstka R., Powell D.J., Kvardova V., Roubalova E., Bourougaa K., Candeias M.M., et al. The novel platinum(IV) complex LA-12 induces p53 and p53/47 responses that differ from the related drug, cisplatin. Anti-cancer Drugs 2008, 19:369-379.
50. Horák D., Kučerová J., Korecká L., Jankovičová B., Palarčík P., Mikulášek P., et al. New monodisperse magnetic polymer microspheres biofunctionalized for enzyme catalysis and bioaffinity separations. Macromol Biosci 2012, 12:647-655.
51. Blums E., Cebers A., Maiorov M.M. Magnetic fluids 1997, 367. de Gruyter, Berlin.
52. Gardineer B.A., Sambucetti C.J. Preparation of magnetite for use in magnetic ink printing. IBM Tech Disclosure Bull 1974, 17:1817-1819.
53. Sidhu P.S. Transformation of trace element-substituted maghemite to hematite. Clay Clay Min 1988, 36:31-38.
54. 3 particles. J Solid State Chem 1998, 137:185-190.
55. Colthup N.B., Daly L.H., Wiberley S.E. Introduction to infrared and Raman spectroscopy 1990, Academic Press, San Diego. 3rd ed.
56. Silverstein R.M., Bassler G.C., Morrill T.C. Spectrometric identification of organic compounds 1991, Wiley, New York. 4th ed.
57. Vojtěšek B., Bártek J., Midgley C.A., Lane D.P. An immunochemical analysis of the nuclear phosphoprotein p53: new monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 1992, 151:237-244.
58. Kvardova V., Hrstka R., Walerych D., Muller P., Matoulkova E., Hruskova V., et al. The new platinum(IV) derivative LA-12 shows stronger inhibitory effect on Hsp90 function compared to cisplatin. Mol Cancer 2010, 9:147.
59. Hermanson G.T. Bioconjugate techniques 2008, 787-826. Academic Press, New York. 2nd ed.